Intended for healthcare professionals


South Africa begins first HIV vaccine trial in seven years

BMJ 2016; 355 doi: (Published 01 December 2016) Cite this as: BMJ 2016;355:i6501
  1. Owen Dyer
  1. Montreal

The stalled search for an elusive vaccine against HIV began again on 30 November with the official start of the HVTN 702 trial in South Africa. The vaccine efficacy study will follow 5400 men and women injected over a year with five doses of either a two part vaccine or placebo. Results are due in 2020.

“HIV has taken a devastating toll in South Africa, but now we begin a …

View Full Text

Log in

Log in through your institution


* For online subscription